Financial statements 4 Pharma

Balance sheet of 4 Pharma

Company age:
Age:
19 y. 9 m. 17 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of 4 PHARMA

Year
2018
2020
2022
2023
Total assets 3 266 741,02 2 957 578,95 3 396 358,54 3 018 467,82
A. Fixed assets 359 204,75 273 378,53 388 626,77 213 487,41
B. Current assets 2 907 536,27 2 684 200,42 3 007 731,77 2 804 980,41
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 3 266 741,02 2 957 578,95 3 396 358,54 3 018 467,82
A. Equity 1 787 363,01 1 299 734,97 1 074 154,25 -412 923,57
B. Liabilities and provisions for liabilities 1 479 378,01 1 657 843,98 2 322 204,29 3 431 391,39
I. Long-term liabilities - - - -
II. Short-term liabilities 1 282 761,02 1 291 865,29 1 690 596,77 2 498 452,34
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.